[go: up one dir, main page]

IT1261849B - Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. - Google Patents

Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Info

Publication number
IT1261849B
IT1261849B ITRM930591A ITRM930591A IT1261849B IT 1261849 B IT1261849 B IT 1261849B IT RM930591 A ITRM930591 A IT RM930591A IT RM930591 A ITRM930591 A IT RM930591A IT 1261849 B IT1261849 B IT 1261849B
Authority
IT
Italy
Prior art keywords
drugs
administration
medical device
active ingredients
low dosage
Prior art date
Application number
ITRM930591A
Other languages
English (en)
Inventor
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Publication of ITRM930591A0 publication Critical patent/ITRM930591A0/it
Priority to ITRM930591A priority Critical patent/IT1261849B/it
Priority to EP94112012A priority patent/EP0641561B1/en
Priority to ES94112012T priority patent/ES2125380T3/es
Priority to DE69414502T priority patent/DE69414502T2/de
Priority to AT94112012T priority patent/ATE173162T1/de
Priority to DK94112012T priority patent/DK0641561T3/da
Priority to CA002129760A priority patent/CA2129760A1/en
Priority to KR1019940020906A priority patent/KR950007808A/ko
Priority to ZA946698A priority patent/ZA946698B/xx
Priority to JP6209599A priority patent/JPH07165566A/ja
Publication of ITRM930591A1 publication Critical patent/ITRM930591A1/it
Priority to US08/528,162 priority patent/US5683712A/en
Application granted granted Critical
Publication of IT1261849B publication Critical patent/IT1261849B/it
Priority to GR990400390T priority patent/GR3029308T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Viene descritto un dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici, costituito da un cerotto transdermico contenente un gel nel quale è disperso il farmaco da somministrare.
ITRM930591A 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. IT1261849B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
EP94112012A EP0641561B1 (en) 1993-09-02 1994-08-02 Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs
ES94112012T ES2125380T3 (es) 1993-09-02 1994-08-02 Dispositivo medico para la administracion de ingredientes activos o medicamentos a dosis muy bajas, en especial medicamentos homeopaticos.
DE69414502T DE69414502T2 (de) 1993-09-02 1994-08-02 Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
AT94112012T ATE173162T1 (de) 1993-09-02 1994-08-02 Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen
DK94112012T DK0641561T3 (da) 1993-09-02 1994-08-02 Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik
CA002129760A CA2129760A1 (en) 1993-09-02 1994-08-09 Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs
KR1019940020906A KR950007808A (ko) 1993-09-02 1994-08-24 약물투여용 의료용구
ZA946698A ZA946698B (en) 1993-09-02 1994-09-01 Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
JP6209599A JPH07165566A (ja) 1993-09-02 1994-09-02 極少量の薬剤の投与のための医療用品
US08/528,162 US5683712A (en) 1993-09-02 1995-09-14 Transdermal patch for the administration of homeopathic drugs
GR990400390T GR3029308T3 (en) 1993-09-02 1999-02-05 Medical device for the administration of active ingredients or drugs at very low doses, particularly homeopathic drugs.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Publications (3)

Publication Number Publication Date
ITRM930591A0 ITRM930591A0 (it) 1993-09-02
ITRM930591A1 ITRM930591A1 (it) 1995-03-02
IT1261849B true IT1261849B (it) 1996-06-03

Family

ID=11401933

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Country Status (12)

Country Link
US (1) US5683712A (it)
EP (1) EP0641561B1 (it)
JP (1) JPH07165566A (it)
KR (1) KR950007808A (it)
AT (1) ATE173162T1 (it)
CA (1) CA2129760A1 (it)
DE (1) DE69414502T2 (it)
DK (1) DK0641561T3 (it)
ES (1) ES2125380T3 (it)
GR (1) GR3029308T3 (it)
IT (1) IT1261849B (it)
ZA (1) ZA946698B (it)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76641C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) * 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
KR101903920B1 (ko) 2005-12-01 2018-11-13 유니버시티 오브 메사츄세츠 로웰 보툴리눔 나노에멀젼
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EP2015773A4 (en) 2006-04-27 2010-05-05 Anterios Inc EXAMINATION OF THE EFFECTS OF TOPICAL ADMINISTRATION OF CHEMICALLY DENOMINATING PHARMACEUTICALS
MX2008015621A (es) * 2006-06-06 2009-03-06 Oleg Iliich Epshtein Agente medicinal para el tratamiento de obesidad, diabetes y enfermedades relacionadas con la tolerancia deteriorada de glucosa.
CN107080703A (zh) 2006-12-01 2017-08-22 安特里奥公司 肽纳米粒子和其用途
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
WO2008116004A2 (en) 2007-03-19 2008-09-25 Vita Sciences, Llc Transdermal patch and method for delivery of vitamin b12
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
KR102080429B1 (ko) 2008-06-26 2020-02-21 안테리오스, 인코퍼레이티드 경피 운반
CZ2013105A3 (cs) 2010-07-15 2013-05-22 Iliich Epshtein@Oleg Zpusob zvýsení úcinku aktivované potencované formy protilátky
SG187035A1 (en) 2010-07-15 2013-02-28 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
JP2013532182A (ja) 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法
JP6158082B2 (ja) 2010-07-17 2017-07-05 メルク パテント ゲーエムベーハー 浸透と作用の増強
ES2425315R1 (es) 2010-07-21 2014-09-08 Oleg Iliich Epshtein Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento sintomático de una enfermedad o afección respiratoria
FR2962911A1 (fr) 2010-07-21 2012-01-27 Oleg Iliich Epshtein Composition pharmaceutique d'association destinee a etre utilisee dans un procede pour traiter le trouble d'hyperactivite avec deficit de l'attention
KR20230007537A (ko) 2011-01-24 2023-01-12 안테리오스, 인코퍼레이티드 나노입자 조성물, 이의 제형, 및 그의 용도
CN109464393A (zh) 2011-01-24 2019-03-15 安特里奥公司 纳米颗粒组合物
WO2012103037A1 (en) 2011-01-24 2012-08-02 Anterios, Inc. Oil compositions
EP2680869A4 (en) * 2011-03-03 2015-04-15 Nancy Josephine Polich HOMEOPATHIC THERAPY PROCEDURES AND COMPOSITIONS
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
PL2683385T3 (pl) 2011-03-10 2018-12-31 Rigel Pharmaceuticals, Inc. 2,4-podstawione pirymidynodiaminy do zastosowania w toczniu krążkowym
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
BE1020027A3 (fr) * 2011-06-23 2013-04-02 Jean Pierre Mageren Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques.
EP2841098A4 (en) 2012-04-23 2016-03-02 Allertein Therapeutics Llc NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
CA2884710A1 (en) 2012-09-12 2014-03-20 Rigel Pharmaceuticals, Inc. Treatment for vitiligo
AU2014248090B2 (en) 2013-04-03 2018-08-02 N-Fold Llc Novel nanoparticle compositions
EP3137082A4 (en) 2014-05-01 2018-02-28 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
CN108024972A (zh) 2015-07-24 2018-05-11 葛兰素集团有限公司 白癜风的治疗
MX2019005833A (es) 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
RU2020123343A (ru) 2017-12-20 2022-01-20 Аллерган, Инк. Полипептиды клеточносвязывающего домена ботулинического токсина и способы применения для омоложения кожи
CN120899921A (zh) 2018-09-13 2025-11-07 艾里奥治疗公司 纤溶酶原激活物抑制剂1(pai-1)抑制剂的用途
CN120983628A (zh) 2018-09-13 2025-11-21 艾里奥治疗公司 纤溶酶原激活物抑制剂1(pai-1)抑制剂和其用途
WO2020117564A1 (en) 2018-12-03 2020-06-11 Eirion Therapeutics, Inc. Improved delivery of large agents
WO2020231983A1 (en) 2019-05-14 2020-11-19 Eirion Therapeutics, Inc. Delaying peak effect and/or extending duration of response
US20210000754A1 (en) 2019-07-02 2021-01-07 Clifford T. Rowley Transdermal patch providing improved permeability and composition
EP4427738A3 (en) 2019-08-02 2024-12-04 Enterin, Inc. Dosing protocols and regimens for aminosterol treatment
WO2025064449A1 (en) 2023-09-18 2025-03-27 Eirion Therapeutics, Inc. Topical compositions and uses of pai-1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
WO1992006701A1 (en) * 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use

Also Published As

Publication number Publication date
DE69414502D1 (de) 1998-12-17
EP0641561B1 (en) 1998-11-11
US5683712A (en) 1997-11-04
ES2125380T3 (es) 1999-03-01
CA2129760A1 (en) 1995-03-03
ZA946698B (en) 1995-05-02
ITRM930591A1 (it) 1995-03-02
GR3029308T3 (en) 1999-05-28
ATE173162T1 (de) 1998-11-15
JPH07165566A (ja) 1995-06-27
DE69414502T2 (de) 1999-04-08
EP0641561A2 (en) 1995-03-08
KR950007808A (ko) 1995-04-15
DK0641561T3 (da) 1999-07-26
EP0641561A3 (en) 1995-09-27
ITRM930591A0 (it) 1993-09-02

Similar Documents

Publication Publication Date Title
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
HUT43948A (en) Emulsion compositions for dosing ionizable hydrophobic medical substances which are little soluble in water and process for preparing the same
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
MX171191B (es) Composiciones farmaceuticas de glipizida
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
DE69105202D1 (de) System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren.
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
ES2072447T3 (es) Locion analgesica externa y procedimiento de preparacion.
ATE225647T1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
ATE292453T1 (de) Antivirale arznei
CY1112964T1 (el) Κιτ για φαρμακευτικη χρηση
ES2139842T3 (es) Uso de la melatonina para tratar a pacientes que sufren drogodependencia.
KR890007728A (ko) 진통제 제조방법
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
Fujita et al. A clinical experience of fosfomycin tablet on cystitis
GT199100015A (es) Metodo para administracion percutanea de ibuprofeno usando un gel hidroalcoholico
ATE257377T1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
RO96749A2 (ro) Medicament vasoactiv
RU94020847A (ru) Транквилизирующее средство

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970714